Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Larimar Therapeutics Inc (LRMR)  
$1.15 0.00 (0.00%) as of 4:30 Tue 6/2


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 39,940,000
Market Cap: 45.93(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $1.15 - $1.15
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Larimar Therapeutics is a clinical-stage biotechnology company focused on developing treatments for patients suffering from rare diseases using its cell penetrating peptide technology platform. Co.'s lead product candidate, CTI-1601, is a biologic fusion protein that is administered subcutaneously, consists of a cell penetrating peptide (CPP) genetically fused to human frataxin (FXN), and includes a mitochondrial targeting sequence. Using its proprietary peptide delivery technology, CTI-1601 carries the molecule from the intravascular space across the cell membrane and into the mitochondria where the CPP and the mitochondrial targeting sequence are cleaved off to yield mature FXN.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 4,297,617 4,297,617 15,802,427
Total Buy Value $0 $37,540,655 $37,540,655 $73,788,059
Total People Bought 0 3 3 8
Total Buy Transactions 0 3 3 10
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-02-22 2023-11-21 2023-05-23 2022-05-23

   
Records found: 107
  Page 2 of 5  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Hughes Thomas E. See Remarks   •       •      –    2018-03-07 4 AS $10.00 $50,000 D/D (5,000) 157,247     -
   Daniel Thomas O Director   –       •      –    2018-01-03 4 A $5.18 $44,999 D/D 8,687 19,452     -
   Lamattina John L Director   –       •      –    2018-01-03 4 A $5.18 $47,495 D/D 9,169 20,532     -
   Heller Frances K Director   –       •      –    2017-10-13 4 B $3.90 $38,988 D/D 10,000 47,961 2.39     -
   Kim Dennis D Chief Medical Officer   •       –      –    2017-07-11 4 B $3.39 $33,900 D/D 10,000 21,443 2.74     -
   Hughes Thomas E. President and CEO   •       •      –    2017-05-11 4 OE $0.75 $74,673 D/D 93,211 157,371     -
   Kim Dennis D Chief Medical Officer   •       –      –    2017-05-11 4 B $4.40 $43,120 D/D 9,800 11,443 2.74     -
   Kim Dennis D Chief Medical Officer   •       –      –    2017-05-10 4 B $4.40 $880 D/D 200 1,643 2.66     -
   Daniel Thomas O Director   –       •      –    2017-02-13 4 A $4.18 $44,998 D/D 10,765 10,765     -
   Lamattina John L Director   –       •      –    2017-02-13 4 A $4.18 $47,497 D/D 11,363 11,363     -
   Heller Frances K Director   –       •      –    2016-12-19 4 B $3.23 $32,290 D/D 10,000 30,000 2.39     -
   Heller Frances K Director   –       •      –    2016-11-15 4 B $3.54 $35,434 D/D 10,000 20,000 2.39     -
   Hughes Thomas E. President and CEO   •       •      –    2016-08-29 4 B $3.00 $29,987 D/D 10,000 63,936 2.81     -
   Allen Patricia L Chief Financial Officer   •       –      –    2016-07-26 4 B $3.15 $25,830 D/D 8,200 19,793 2.74     -
   Allen Patricia L Chief Financial Officer   •       –      –    2016-07-25 4 B $3.08 $24,032 D/D 7,800 11,593 2.74     -
   Hughes Thomas E. President and CEO   •       •      –    2016-07-22 4 B $3.02 $15,104 D/D 5,000 53,936 2.81     -
   Hughes Thomas E. President and CEO   •       •      –    2016-07-22 4 OE $0.75 $18,750 D/D 25,000 48,936     -
   Heller Frances K Director   –       •      –    2016-07-22 4 B $2.99 $29,900 D/D 10,000 10,000 2.39     -
   Deerfield Special Situations Fund, L.p. Possible Member of 10% Group   –       –       •   2016-07-20 4 S $3.31 $4,442,776 I/I (1,341,499) 1,151,802     -
   Mcdonough Cameron Geoffrey Director   –       •      –    2016-04-01 4 D $7.91 $34,994 D/D (4,424) 0     -
   Deerfield Special Situations Fund, L.p. Possible Member of 10% Group   –       –       •   2016-02-12 4 B $6.25 $403,187 I/I 64,545 2,053,232 1.5     -
   Deerfield International Master Fund, L.p. Possible Member of 10% Group   –       –       •   2016-02-11 4 B $6.19 $14,506 I/I 2,344 2,039,360 1.5     -
   Deerfield International Master Fund, L.p. Possible Member of 10% Group   –       –       •   2016-02-10 4 B $6.23 $942,486 I/I 151,226 2,038,856 1.5     -
   Deerfield International Master Fund, L.p. 10% Owner   –       –       •   2016-02-09 3 IO $0.00 $0 I/I 0 2,723,565     -
   Deerfield International Master Fund, L.p. Possible Member of 10% Group   –       –       •   2016-02-09 4 B $5.73 $652,676 I/I 113,923 2,006,355 1.5     -
  107 Records found
  1  2  3  4  5   
  Page 2 of 5
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us